IPNews® – A judge recently ruled that the patent for a prenatal test should not have been issued to San Diego based bio-tech company Sequenom.

Sequenom received the patent for the pre-natal test called MaterniT21.  However, a judge ruled that this patent should never have been awarded on the grounds that it covered a “natural phenomenon.”    To continue reading, click:  Sequenom Prenatal Test Patent Ruled Invalid